|Age:||18 years and older|
|Keywords:||neurofibromatosis type 1, NF1, Gel, NFX-179, dermal neurofibromas, cutaneous neurofibromas|
|Type:||Phase 2, Drug Study|
Your participation in this study will last approximately 88 days and includes 7 study visits to the study center:
To fully determine if you are eligible to participate in this study, the study team will need to verify additional criteria by phone and in-person at the clinic.
Have any questions or want to learn more? Leave your contact details below and the research team will reach out to you.